A collaboration between two leading biotech companies, the South Africa-based Afrigen and the Belgium-based Univercells will work together to develop a novel regional mRNA vaccine. The companies intend to confront the lack of local cost-effective production and the need for cold or super-cold chains that have hampered vaccination thus far.
Before the COVID pandemic, efforts to address the challenge of limited vaccine production on the continent yielded little success.
Companies are moving their production back to developed countries. This is jeopardising the decades-long progress in global poverty reduction.
A highlight of this pandemic is how quickly effective vaccines were developed and rolled out.
COVID-19’s two year anniversary has been eclipsed by a European war, but the devastating effects of the pandemic are glaring. From strained relationships, loss, painful break-ups to the creation of a new class of nouveaux riche, referred to in Kenya as “COVID-19 billionaires”, the pandemic has had a far-reaching impact. Dauti Kahura reflects.
In this week’s cartoon we reflect on the two years since the Coronavirus and COVID-19 were declared a global public health emergency.
The EU has blocked proposals by the AU that would allow the generic production of COVID-19 vaccines, tests, and treatments and is now set to throw away 55 million doses of COVID-19 vaccines that could have been donated.
There’s a new COVID lineage called B.1.1.529. It has a genetic profile very different from other circulating variants.
The world needs to learn to live with the virus. And governments must follow the science and don’t distort it for political expediency.